Overweight Clinical Trials in Lenexa, Kansas

4 studies are recruiting for overweight in Lenexa, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

    The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity and type 2 diabetes mellitus. Trial 20210182 is extension of trial 20210184 (NCT06858878).

    Stage
    Phase 3
    Ages
    18 to 99
    Site
    JCCT- Juno Northwest Houston, Lenexa, Kansas
    Locations
    45 in total
    Run by
    Amgen

    See if you can join NCT07684144 on ClinicalTrials.gov

  2. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

    The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity or overweight. Trial 20250197 is an extension of trial 20210181 (NCT06858839).

    Stage
    Phase 3
    Ages
    18 to 99
    Site
    JCCT- Juno Northwest Houston, Lenexa, Kansas
    Locations
    92 in total
    Run by
    Amgen

    See if you can join NCT07684235 on ClinicalTrials.gov

  3. A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

    The purpose of the study is to find out if NNC0721-8060 is safe and how it works in people living with overweight or obesity.

    Stage
    Phase 1
    Ages
    18 to 55
    Site
    ICON Early Phase Services, LLC, Lenexa, Kansas
    Locations
    2 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07767175 on ClinicalTrials.gov

  4. A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

    This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in studies and is not yet available for prescription by doctors. In this study, participants will receive either NNC6989-0001…

    Stage
    Phase 1
    Ages
    18 to 55
    Site
    ICON Early Phase Services, LLC, Lenexa, Kansas
    Run by
    Novo Nordisk A/S

    See if you can join NCT07437079 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.